BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 15499154)

  • 1. Glucose-6-phosphate dehydrogenase activity in male premature and term neonates.
    Mesner O; Hammerman C; Goldschmidt D; Rudensky B; Bader D; Kaplan M
    Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F555-7. PubMed ID: 15499154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative challenge and glucose-6-phosphate dehydrogenase activity of preterm and term neonatal red blood cells.
    Ko CH; Wong RP; Ng PC; Li K; Chui KM; Yuen PM; Fok TF
    Neonatology; 2009; 96(2):96-101. PubMed ID: 19258737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in preterm and low-birth-weight infants in Israel.
    Ashkenazi S; Mimouni F; Merlob P; Reisner SH
    Isr J Med Sci; 1983 Dec; 19(12):1056-8. PubMed ID: 6662695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates.
    Abolghasemi H; Mehrani H; Amid A
    Clin Biochem; 2004 Mar; 37(3):241-4. PubMed ID: 14972648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant profiles in full term and preterm neonates.
    Lee YS; Chou YH
    Chang Gung Med J; 2005 Dec; 28(12):846-51. PubMed ID: 16515018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early neonatal bilirubin, hematocrit, and glucose-6-phosphate dehydrogenase status.
    Badejoko BO; Owa JA; Oseni SB; Badejoko O; Fatusi AO; Adejuyigbe EA
    Pediatrics; 2014 Oct; 134(4):e1082-8. PubMed ID: 25246627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-6-phosphate dehydrogenase deficiency and borderline deficiency: association with neonatal hyperbilirubinemia.
    Riskin A; Gery N; Kugelman A; Hemo M; Spevak I; Bader D
    J Pediatr; 2012 Aug; 161(2):191-6.e1. PubMed ID: 22459229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia.
    Wang FL; Boo NY; Ainoon O; Wong MK
    Singapore Med J; 2009 Jan; 50(1):62-7. PubMed ID: 19224086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it accurate to separate glucose-6-phosphate dehydrogenase activity in neonatal hyperbilirubinemia as deficient and normal?
    Kilicdag H; Gökmen Z; Ozkiraz S; Gulcan H; Tarcan A
    Pediatr Neonatol; 2014 Jun; 55(3):202-7. PubMed ID: 24326153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females.
    Ainoon O; Alawiyah A; Yu YH; Cheong SK; Hamidah NH; Boo NY; Zaleha M
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):405-14. PubMed ID: 12971572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.
    Azma RZ; Hidayati N; Farisah NR; Hamidah NH; Ainoon O
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):982-8. PubMed ID: 21073074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinaemia: Hacettepe experıence.
    Celik HT; Günbey C; Unal S; Gümrük F; Yurdakök M
    J Paediatr Child Health; 2013 May; 49(5):399-402. PubMed ID: 23573906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular malformations among preterm infants.
    Tanner K; Sabrine N; Wren C
    Pediatrics; 2005 Dec; 116(6):e833-8. PubMed ID: 16322141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates.
    Miao JK; Chen QX; Bao LM; Huang Y; Zhang J; Wan KX; Yi J; Wang SY; Zou L; Li TY
    Clin Chim Acta; 2013 Sep; 424():131-5. PubMed ID: 23680071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates.
    Murki S; Dutta S; Narang A; Sarkar U; Garewal G
    J Perinatol; 2005 May; 25(5):325-30. PubMed ID: 15716985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G6PD-deficient donor blood as a cause of hemolysis in two preterm infants.
    Mimouni F; Shohat S; Reisner SH
    Isr J Med Sci; 1986 Feb; 22(2):120-2. PubMed ID: 3949489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.
    Wolach B; Ashkenazi M; Grossmann R; Gavrieli R; Friedman Z; Bashan N; Roos D
    Pediatr Res; 2004 May; 55(5):807-13. PubMed ID: 14973180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype.
    Algur N; Avraham I; Hammerman C; Kaplan M
    J Pediatr; 2012 Aug; 161(2):197-200. PubMed ID: 22494872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for glucose-6-phosphate dehydrogenase deficiency in Isfahan, Iran: a quantitative assay.
    Iranpour R; Hashemipour M; Talaei SM; Soroshnia M; Amini A
    J Med Screen; 2008; 15(2):62-4. PubMed ID: 18573772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.